로딩 중…
지수 로딩 중…
우진비앤지
018620· KOSDAQ· Health Care· Pharmaceuticals, Biotechnology & Life Sciences
₩2,740-0.72%
2026-11-02
Financials
Valuation Metrics
우진비앤지's Market Cap is ₩190B. At end of 2025 it was ₩240B. Ranked #2299 of 2,405 in KR market (top 96%), #1535 of 1,627 on KOSDAQ (top 94%), #226 of 231 in Pharmaceuticals, Biotechnology & Life Sciences (top 98%) by Market Cap.
Investment Metrics(as of 2026-11-02)
| Metric | Value | Rank |
|---|---|---|
| Size | ||
| Market Cap | 19.00B KRW | KR#2,299/2,405 Sec#226/231 |
| Revenue | 56.49B KRW | KR#1,726/2,405 Sec#117/231 |
| Net Income | -3.48B KRW | KR—/2,405 Sec—/231 |
| Total Assets | 109.35B KRW | KR#1,703/2,405 Sec#133/231 |
| Net Assets | 66.30B KRW | KR#1,717/2,405 Sec#146/231 |
| Employees | 98 | KR#1,642/2,405 Sec#129/231 |
| Value | ||
| P/B | 0.29x | KR#355/2,405 Sec#13/231 |
| P/S | 0.34x | KR#704/2,405 Sec#19/231 |
| EV/EBITDA | 19.63x | KR#1,039/2,405 Sec#62/231 |
| FCF Yield | 5.60% | KR#848/2,405 Sec#46/231 |
| Profitability | ||
| ROE | -5.24% | KR#1,803/2,405 Sec#131/231 |
| ROA | -3.18% | KR#1,837/2,405 Sec#131/231 |
| Op. Margin | 3.14% | KR#1,231/2,405 Sec#88/231 |
| Revenue Growth | 6.10% | KR#1,124/2,405 Sec#111/231 |
| Financial Health | ||
| Debt Ratio | 64.94% | KR#1,149/2,405 Sec#137/231 |
| Total Debt | 30.54B KRW | KR#1,217/2,405 Sec#92/231 |
| FCF | 1.06B KRW | KR#1,138/2,405 Sec#84/231 |
| Cash | 14.72B KRW | KR#1,443/2,405 Sec#115/231 |
| Current Ratio | 1.51x | KR#1,180/2,405 Sec#129/231 |
| Net Debt/EBITDA | 8.92x | KR#1,178/2,405 Sec#86/231 |
| Performance | ||
| 1Y Return | -24.91% | KR#1,269/2,405 Sec#93/231 |
| 1M Return | 2.81% | KR#215/2,405 Sec#23/231 |
| From 52W High | -37.18% | KR#658/2,405 Sec#42/231 |
| 1Y MDD | -39.84% | KR#558/2,405 Sec#38/231 |
| Trading | ||
| Volume | 9,056 shares | KR#1,887/2,405 Sec#189/231 |
| Trading Value | 24.9M KRW | KR#2,020/2,405 Sec#210/231 |
| Foreign Own. | 1.82% | KR#1,686/2,405 Sec#163/231 |
| Per Share | ||
| EPS | -502 KRW | KR—/2,405 Sec—/231 |
| BPS | 9,563 KRW | KR#1,027/2,405 Sec#71/231 |
Company Info
동사는 1985년 동물용 의약품 제조 및 판매를 위해 설립되어 2008년 코스닥시장에 상장함. 동물용의약품과 인체원료의약품, 미생물제제, 백신 등을 제조·판매하고 있음. 동사의 종속회사들은 반려동물용 사료 및 간식 제조 사업을 영위함. 최근 반려동물 입양문화가 급속히 확산됨에 따라, 당사는 반려동물의 연령과 건강 상태를 고려한 기능성 간식과 처방식 사료 제품 개발에 주력하고 있음. 우진비앤지는 1985년에 설립되었으며 경기도 화성시에 본사를 두고 있습니다.